Brouet J C, Dellagi K, Gendron M C, Chevalier A, Schmitt C, Mihaesco E
Laboratory of Immunochemistry and Immunopathology, Institut National de la Santé et de la Recherche Médicale, Hôpital Saint-Louis, Paris, France.
J Exp Med. 1989 Nov 1;170(5):1551-8. doi: 10.1084/jem.170.5.1551.
Most studies using rabbit or mouse antisera failed to detect CRI between human IgM directed to MAG. We show here that 9 of 10 such IgM express a public CRI as defined by a nonhuman primate antiserum. Shared idiotype is likely involved in (or close to) the combining site of those IgM since antiidiotypic serum inhibited the binding of IgM to MAG and reacted with IgM having different variable regions of light and heavy chains. Partial aminoterminal sequence of heavy and light chains showed that anti-MAG IgM use either lambda chains (one IgM) or kappa light chains (six IgM) of different variability subgroups (V kappa IV in three instances, V kappa I in two, and V kappa II in one), whereas heavy chains belong to the VHIII (six IgM) or to the VHII (1 IgM) subgroup. These features distinguish these IgM from other human monoclonal IgM with a defined antibody activity, such as rheumatoid factors or cold agglutinins.
大多数使用兔或鼠抗血清的研究未能检测到针对髓鞘相关糖蛋白(MAG)的人IgM之间的交叉反应性免疫球蛋白(CRI)。我们在此表明,10份此类IgM中有9份表达了一种由非人灵长类动物抗血清定义的公共CRI。共享独特型可能与这些IgM的结合位点相关(或接近结合位点),因为抗独特型血清抑制了IgM与MAG的结合,并与具有不同轻链和重链可变区的IgM发生反应。重链和轻链的部分氨基末端序列显示,抗MAG IgM使用不同可变亚组的λ链(1份IgM)或κ轻链(6份IgM)(3例为VκIV,2例为VκI,1例为VκII),而重链属于VHIII亚组(6份IgM)或VHII亚组(1份IgM)。这些特征将这些IgM与其他具有明确抗体活性的人单克隆IgM区分开来,如类风湿因子或冷凝集素。